Viewing nowCombinationTelmisartan 80/5 mg Tablets
Telmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Unimed Pharmaceuticals Co., Ltd.

MFDS item code 201804338 · Approved 2018.10.31 · Insurance code 649507810
Treatment of essential hypertension not controlled with monotherapy
Used for essential hypertension that is not adequately controlled by monotherapy with telmisartan or amlodipine.
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before administering this medicine, it is recommended to adjust the dose using the individual components (amlodipine or telmisartan); however, if blood pressure is not controlled with the individual components as follows, switching directly to this medicine may be considered. - 40/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medicine 40/5 milligrams. - 40/10 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. ◦ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment; however, in patients with severe renal impairment, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring cautious administration’). In elderly patients aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.
This medicine should not be used during pregnancy, especially during the second and third trimesters, as it can pose serious risks to the fetus. If pregnancy is confirmed, this medicine should be discontinued immediately. This drug is contraindicated for patients with specific diseases such as severe liver or heart dysfunction, hypotension, shock, and those with hypersensitivity to certain medications. Furthermore, women who could become pregnant or are breastfeeding should not take this medicine. Caution is required when administering this drug to patients with impaired liver or kidney function, specific heart valve diseases, active gastrointestinal diseases, or renovascular hypertension which necessitates strict medical observation. Side effects such as dizziness or edema may commonly occur during the course of treatment, so caution is advised. If symptoms of significantly low blood pressure or serious side effects occur, medical consultation should be obtained immediately. Additionally, this medicine may interact with other medications, and it is essential to inform the doctor or pharmacist about other medications being taken. Extra caution is warranted when administering this medicine to the elderly, and dose adjustments may be necessary. Overdose may lead to hypotension, cardiac arrhythmias, and impaired kidney function, requiring immediate medical treatment. Finally, the safety and efficacy of this drug in children have not been sufficiently established, hence its use is not recommended.
Not everyone experiences these, and they can vary from person to person.
This medicine may be sensitive to light; therefore, it should be stored in a tightly sealed container that is protected from light. The storage temperature should be maintained between 1 to 30 degrees Celsius. Storing it this way will help maintain the drug's efficacy safely.
It is a white to light gray, double convex, oval tablet.
30 tablets (10 tablets/PTP × 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Unimed Pharmaceuticals Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.